<PAGE>
Exhibit 23.1
The Board of Directors
InKine Pharmaceutical Company, Inc.
We consent to incorporation by reference in the registration statements Nos.
333-42647, 333-37254 and 333-89365 on Form S-3 and Nos. 333-33898, 333-58063 and
333-58065 on Form S-8 of InKine Pharmaceutical Company, Inc. of our report dated
August 4, 2000, except for Note 1 which is as of September 21, 2000, relating to
the balance sheets of InKine Pharmaceutical Company, Inc. as of June 30, 2000
and 1999, and the related statements of operations, changes in shareholders'
equity and cash flows for each of the years in the three-year period ended June
30, 2000 which report appears in the annual report on Form 10-K of InKine
Pharmaceutical Company, Inc.
/s/ KPMG LLP
Philadelphia, Pennsylvania
September 25, 2000
